Our Team

Executive Team

Emile Nuwaysir, Ph.D.

President and CEO

Robert Deans, Ph.D.

Chief Technology Officer

Shane Kovacs

Chief Business and Financial Officer

Min Wang, J.D., Ph.D.

Chief Legal and Administrative Officer

Joachim Fruedis, Ph.D.

Chief Development Officer

Michael Scott, Ph.D.

Senior Vice President, Product Development

Derek Hei, Ph.D.

Senior Vice President, Manufacturing, Quality and Regulatory

Tracey Lodie, Ph.D.

Senior Vice President, Translational Immunology

Andrea Brener

Head of Human Resources

Scientific Founders and Founding Investigators

Gordon Keller, Ph.D.

BlueRock Scientific Founder
Director, McEwen Centre for Regenerative Medicine, University Health Network

Michael Laflamme, M.D., Ph.D.

BlueRock Founding Investigator
Senior Scientist, Toronto General Hospital Research Institute, University Health Network

Lorenz Studer, M.D., Ph.D.

BlueRock Scientific Founder
Director of Stem Cell Biology, Memorial Sloan Kettering Cancer Center

Viviane Tabar, M.D.

BlueRock Founding Investigator
Chair, Department of Neurosurgery; Theresa Feng Chair in Neurosurgical Oncology

Board of Directors

Brad Bolzon, Ph.D.

Managing Director, Versant Ventures

Axel Bouchon, Ph.D.

Head, Bayer Lifescience Center

Jerel Davis, Ph.D.

Managing Director, Versant Ventures

Jurg Eckhardt, M.D.

Head, Bayer Venture Investments

Emile Nuwaysir, Ph.D.

President & CEO, BlueRock Therapeutics


BlueRock strategically partners with biopharmaceutical companies, leading academic and medical institutions and other leading industry organizations that are aligned with its mission to develop regenerative medicines for intractable diseases. BlueRock’s collaborators include top international doctors, scientists, and organizations specializing in the areas of cell therapy, cell reprogramming, Neurology, Cardiology, and Autoimmunity.

Memorial Sloan Kettering Cancer Center

McEwen Centre for Regenerative Medicine, University Health Network


iPS Academia Japan

Interested in partnering with BlueRock?

We are actively seeking strategic relationships with biopharmaceutical companies and academic researchers interested in collaborating to advance a versatile cell therapy approach centered on induced pluripotent stem cells.

Contact Us

Over the next 12 months, BlueRock will be significantly expanding staff at all locations. Contact us to learn about our rewarding career opportunities in New York, Boston/Cambridge, and Toronto.

Toronto, ON
BlueRock Toronto
MaRS Discovery District
101 College Street,
East Tower,
15-701 Toronto, ON
M5G 1L7, Canada

New York, NY
BlueRock New York
36 E 31st Street, Suite 602
New York, NY 10016, USA

Cambridge, MA
BlueRock Corporate Headquarters
1 Broadway
Cambridge, MA 02142, USA

Receive Corporate Updates